The CEOs are tripping. Can psychedelics help the C-suite?
A growing cottage industry is dedicated to the theory that mind-altering drugs can improve business leadership.
Burrowed in the foothills of the Canadian Rockies is a wooden house, a retreat centre made of pine and spruce and filled with mushroom carvings, tapestries of periwinkle and indigo paisley, books about The Indoctrinated Brain and other paraphernalia nodding to the promised transformation: enter as a chief executive, emerge as an enlightened one.
When a group of executives wearing hoodies and leggings arrived on a Tuesday evening in October, they vibrated with the nervous energy of summer camp drop-off. They were gathered for a retreat called “The Psychedelic CEO”, which they had agreed to let me observe.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles